July 13, 2023 – Sekisui Diagnostics has announced that Luke Christensen has joined the company on July 6th as the Global Vice President of Sales.
Luke will be responsible for managing the IVD business sales as well as having shared responsibility for portions of the diagnostic enzyme sales ensuring the successful execution of the company’s sales strategy and for managing the budget for his areas of responsibility.
Luke brings with him over 20 years of sales experience as a leader with a solid history of growth and active participation in advancing the interests of Laboratory based businesses. His career began at McKesson Medical-Surgical in Customer Service and then shifted into Sales where he started as a local Account Manager and progressed to an Area Sales Manager. Following his Area Sales Manager assignment, Luke was promoted in 2014 to Vice President, Laboratory Sales – Primary Care. During his time in this role he grew his team from 8 to 35 laboratory sales professionals and helped double McKesson’s business in this area to $1.2B annually. In 2020 Luke was promoted into the role of Vice President, Laboratory Sales where he was a key player in focusing McKesson’s business on addressing market needs stemming from the COVID-19 pandemic as well as all other laboratory testing, generating over $3.0B in revenue and placing over 125,000 new analyzers in the market since 2020.
He is also considered a clinical lab industry thought leader who has participated in multiple speaking engagements as a Health Industry Distributors Association (HIDA) Lab Council Chair, American Association for Clinical Chemistry (AACC) member/speaker, and a McKesson Government Affairs SME.